Sevirumab
Names
[ CAS No. ]:
138660-96-5
[ Name ]:
Sevirumab
Biological Activity
[Description]:
Sevirumab (MSL-109) is a human IgG1 neutralizing monoclonal antibody against cytomegalovirus (CMV). Sevirumab recognizes CMV gH complexes and inhibits CMV replication with an EC50 of 0.3 μg/mL[1][2].
[Related Catalog]:
[Target]
EC50: 0.3 μg/mL (CMV)[1]
[In Vitro]
Sevirumab (MSL-109) 扰乱 gH/gL 同型二聚体,而不是取消二聚。Sevirumab 可以将二聚体在足够的距离上分开,以减少荧光共振能量转移 (FRET),并最终阻止正常的 gH/gL 功能[2]。
[References]
Chemical & Physical Properties
No Any Chemical & Physical Properties